Simon Draper

Exciting data from a human malaria re-challenge model deciphering how humans become immunologically tolerant to falciparum #malaria. Big thanks to fantastic collaborators @spence_lab.

Thanks to global immunisation efforts, an estimated 154 million lives have been saved over the past 50 years 🌎 🤝 That’s equivalent to 6 lives every minute. #CelebrateVaccines

Great podcast by Andrew Duncan explaining our latest P. vivax malaria challenge clinical trial. Part of the #OptiVivax Consortium working with the @OxfordVacGroup and @KavliOxford ovg.ox.ac.uk/studies/bio006 @OxPaediatrics @OxfordMedSci @UniofOxford @KavliFoundation

#OptiViVax launches a first-in-kind clinical trial, BIO-006, with the @OxfordVacGroup to investigate relapsing malaria infection caused by Plasmodium vivax. Find out more here: optivivax.web.ox.ac.uk/article/draper… @KavliOxford @OxfordMedSci @UniofOxford @KavliFoundation @OxPaediatrics

@KavliOxford @OptiVivax

Our group's new BIO-006 clinical trial on #vivax #malaria is recruiting now in Oxford. The first trial in our @OptiVivax consortium. Aiming to assess relapsing malaria infection - check out the link below 👇

📢 Sign up for BioMalPar XXI and join us in this crucial endeavour to understand the biology of the malaria parasite and to advance global health 🌍⚕️#EMBLMalaria 👉🏻 s.embl.org/bmp25-01-x Topics 🦟 Epidemiology 🦟 Vaccines & immunity 🦟 Vector & transmission 🦟 Molecular & cellular biology 🦟 Drug targets & resistance 📅 20 – 22 May 2025 📍 EMBL Heidelberg and Virtual 📝 Submit your abstract by 25 Feb!

🦟 #Malaria remains a major global health challenge, with rising deaths and drug resistance adding urgency to the fight. 🌍🤝 Join us for the 21st edition of #EMBLMalaria as we strengthen partnerships, share insights, and drive innovations to combat malaria's toll and advance global health 👉🏻 s.embl.org/bmp25-01-x 'BioMalPar XXI: biology and pathology of the malaria parasite' 📅 20 – 22 May 2025 📍 EMBL Heidelberg and Virtual 📝 Submit your abstract by 25 Feb @lilimancio

NEWS: First vaccine against blood-stage malaria is well-tolerated and offers effective protection The study showed that the new vaccine (RH5.1/Matrix-MTM) was well tolerated with no safety concerns, working by reducing the parasite level in the blood. medsci.ox.ac.uk/news/first-vac…

Big thanks to funders and support from @EDCTP, @USAID, #NIAID, @KavliOxford, @BiochemOxford, @JennerInstitute, @The_MRC, @wellcometrust, @OxfordBRC, and @OxPaediatrics.

Big congrats to H. Magloire Natama, Jo Salkeld, Sarah Silk, @halidou_tinto and Angela Minassian and all the teams who have supported this work @UniofOxford, @URCNNanoro, #NIAID, @LSHTM, @SerumInstIndia, @Novavax, and @ExpreS2ionB.

Delighted to share our first safety and efficacy data on the RH5.1/Matrix-M blood-stage #malaria #vaccine in 5-17 month old children in Burkina Faso published @TheLancetInfDis. thelancet.com/journals/lanin…

Ahead of his retirement lecture today, we celebrate the extraordinary career of Professor Sir Brian Greenwood, a pioneer in global health and malaria research. Read more about his remarkable contributions👇 bit.ly/3AXUrxH

The French Riviera of the East beckons!! Come, join us for the 9th ICPvR, hosted by ICMR-VCRC.

🎙️ISV Global Webinar Series 👉6th December 2024 
07:00 (PST) | 1:00 (EST) | 17:00 (South Africa) | 20:30 (IST) 

 Title: "Vaccines against Outbreak Pathogens - what next?" by Dr Teresa Lambe @jenneratingVacc @UniofOxford 👉Join us: #success" target="_blank" rel="nofollow noopener">zoom.us/j/92532088081#…

🦟Exciting News! Registrations are now open for the Malaria MOOC! 👉 Enroll Now : fun-mooc.fr/en/courses/mal… The MOOC provides an overview of malaria today, from the cellular biology of the parasite to treatments, from immune response to control and elimination strategies.

PREVENTION: The Invisible Future of Health - Sir Andrew Pollard The 17th Unither Baruch Blumberg Lecture 4:30pm Wednesday 13th November 2024 Oxford University Museum of Natural History Parks Road, Oxford OX1 3PW

Big congrats to @TheBeiLab, @LatyGaye and their team on the first analysis of #RH5 blood-stage #malaria human #mAbs against P. falciparum clinical isolates in Senegal. Encouraging for strain-transcendence. Check out their great paper @Nature_NPJ below👇

"Malaria is as old as Egyptian civilization itself, but the disease that plagued pharaohs now belongs to its history and not its future." - @DrTedros @WHO YES! Congratulations go out to 🇪🇬 EGYPT on being certified #ZeroMalaria 👏